Culagbang, Rhea B.

HRN: 05-79-04  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
06/30/2022
07/07/2022
IV
88mg
Q8
Infected Retained Placenta And Unrepaired Episiotomy
Waiting Final Action 
06/30/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
06/30/2022
06/30/2022
IV
117mg
As Loading Dose
Infected Retained Placenta And Unrepaired Episiotomy
Waiting Final Action 
06/30/2022
AMPICILLIN 1GM (VIAL)
06/30/2022
07/07/2022
IV
2gm
As Loading Dose Then Q6
Infected Retained Placenta And Unrepaired Episiotomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: